JANES, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 1915
EU - Europa 528
AS - Asia 120
Continente sconosciuto - Info sul continente non disponibili 3
Totale 2566
Nazione #
US - Stati Uniti d'America 1906
UA - Ucraina 194
IT - Italia 157
DE - Germania 76
CN - Cina 71
FI - Finlandia 57
SE - Svezia 25
IR - Iran 14
VN - Vietnam 14
TR - Turchia 11
CA - Canada 9
IN - India 8
FR - Francia 6
BE - Belgio 4
EU - Europa 3
GB - Regno Unito 3
RU - Federazione Russa 3
KR - Corea 2
NL - Olanda 2
PL - Polonia 1
Totale 2566
Città #
Ann Arbor 338
Woodbridge 279
Fairfield 191
Houston 140
Jacksonville 138
Dearborn 114
Wilmington 88
Chandler 82
Seattle 69
Ashburn 64
Cambridge 58
Princeton 49
Udine 39
Venezia 36
Trieste 34
Beijing 32
San Diego 20
Redmond 15
Dong Ket 14
Norwalk 13
Izmir 11
Zanjan 8
Andover 6
Falls Church 6
Toronto 6
Hefei 5
Nanchang 5
Nanjing 5
Augusta 4
Brussels 4
Kunming 4
Nove 4
Guangzhou 3
Leawood 3
Maserada Sul Piave 3
Chongqing 2
Grafing 2
Henderson 2
Indiana 2
Mumbai 2
Sacramento 2
Terni 2
Winnipeg 2
Baotou 1
Buffalo 1
Campoformido 1
Cedar Rapids 1
Changchun 1
Chaoyang 1
Chengdu 1
Fuzhou 1
Helsinki 1
Jinan 1
Kashan 1
Lanzhou 1
Monmouth Junction 1
Mountain View 1
Nanning 1
New Delhi 1
Ottawa 1
Padova 1
Redwood City 1
Ruda 1
San Jose 1
Shanghai 1
Shenyang 1
Taizhou 1
Xian 1
Xining 1
Totale 1932
Nome #
Incidence of transient ischemic attack and early stroke risk: validation of the ABCD2 score in an Italian population-based study. 137
Are Early Seizures Predictive of Epilepsy after a Stroke? Results of a Population-Based Study 117
ADMA as a possible marker of endothelial damage. A study in young asymptomatic patients with cerebral small vessel disease. 106
Prevalence of Restless Legs Syndrome in Migraine Patients: A Case-Control Study. Analysis of Risk Factors for Restless Legs Syndrome in Migraine Patients 99
A case of myelitis with features of late onset systemic lupus erythematosus 98
Identification of stroke etiology may contribute to improve the outcome in dedicated units 94
Electroencephalographic Evaluation for Early Diagnosis of Limbic Encephalitis 89
Stroke incidence and 30-day and six-month case fatality rates in Udine, Italy: a population-based prospective study. 88
Prediction of late seizures after ischaemic stroke with a novel prognostic model (the SeLECT score): a multivariable prediction model development and validation study 88
Changes of cortical excitability after dopaminergic treatment in restless legs syndrome 88
Drugs with anticholinergic properties as a risk factor for cognitive impairment in elderly people: a population based study 84
Stroke incidence and 28-day case fatality rates: the Udine stroke registry 71
NBIA: genetic-clinic-radiologic correlation in a family setting of PANK2 mutation 70
Letter by D'Anna et al regarding article, "Long-term mortality in patients with stroke of undetermined etiology". 70
ABCD2 score validation in Italy. Tia incidence and 2, 7, 30 and 90-day stroke risk 69
G. Crossed aphasia: a case report 69
ABD2 SCORE VALIDATION IN ITALY. TIA INCIDENCE AND 2, 7, 30 AND 90 DAY STROKE RISK 64
Pretreatment d-dimer levels in acute ischemic stroke predict reperfusion after intravenous thrombolysis 62
Crossed aphasia: a case report. 61
6 months post-stroke depression: prevalence and outcome correlation in Udine, Italy 58
Stroke incidence, 6-months case fatalithy rates and out come in Udine, Italy. A population-based prospective study 58
NBIA: genetic-clinic-radiologic correlation in a family setting of pank2 mutation. In: Neurological Sciences. 57
The effect of drugs with anticholinergic activity on cognitive and neuropsychiatric symptoms in Alzheimer disease 56
Stroke Unit care versus Medical Ward for acute ischemic stroke patients: an observational follow-up study 56
Stroke incidence, 6-months case fatality rates and out come in Udine, Italy. A population-based prospective study 55
MARKERS BIOLOGICI DI RICANALIZZAZIONE E DI EFFICACIA CLINICA DEL TRATTAMENTO CON r-tPA NELL'ICTUS CEREBRALE ISCHEMICO ACUTO 54
Post-stroke seizures and epilepsy: incidence and predictors in a population based study 53
Transient Ischemic attack incidence and 28-day prognosis: the Udine stroke registry 51
Asymmetrical Dimethylarginine (ADMA) In Asympomatic Cerebral Small Vessel Disease. 49
A case of recurrent cerebral embolic ischemic stroke caused by atrial myxoma 49
Predictors of letality and of 30 days and 6 months functional impairment in Udine stroke registry 44
Attacco ischemico transitorio e rischio di ictus a breve termine. 44
Transient Ischemic Attack Incidence and 2-, 7- and 30-Day Prognosis in Udine, Italy. A Population-Based Prospective Study 42
Stroke incidence and 30-day case fatality rates in Udine, Italy : a population-based prospective study 33
May lamotrigine be an alternative to topiramate in the prevention of migraine with aura? Results of a retrospective study 33
Is the Asymmetric Dimethylarginine (ADMA) the Possible Molecule Driving Endothelial Damage in Young Asymptomatic Patients with Cerebral Small Vessel Disease? 30
The Effect of Serum of Cerebral Small Vessel Disease Patients on Brain Endothelial Cells 26
A large biomarker investigation in young asymptomatic patients with cerebral vessel disease identified ADMA as a possible key molecule driving endothelial damage. 25
Novel Associations of BST1 and LAMP3 with Rapid Eye Movement Sleep Behavior Disorder 24
Cerebrovascular risk in restless legs syndrome: Intima-media thickness and cerebral vasomotor reactivity: A case–control study 22
Comprehensive Analysis of Familial Parkinsonism Genes in Rapid-Eye-Movement Sleep Behavior Disorder 19
Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies 17
Clinical and neurophysiological effects of botulinum neurotoxin type a in chronic migraine 16
Response to Letter to the Editor on the article “Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination” 16
Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination 15
Seizures after ischemic stroke: a matched multicenter study 15
Failure of Therapeutic Anticoagulation in COVID-19 Patients With Acute Ischemic Stroke. A Retrospective Multicenter Study 15
Brain Exosomes: Friend or Foe in Alzheimer’s Disease? 10
Rare PSAP Variants and Possible Interaction with GBA in REM Sleep Behavior Disorder 7
Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease 3
Creutzfeldt-Jakob disease after COVID-19: infection-induced prion protein misfolding? A case report 2
Correction: Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease (Translational Neurodegeneration, (2022), 11, 1, (37), 10.1186/s40035-022-00311-3) 1
Totale 2679
Categoria #
all - tutte 4130
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4130


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018257 0000 024 19235 4002
2018/2019172 3224 00 133 1336330
2019/2020678 26391988 42137 7674 4280847
2020/2021446 542170 444 3145 106175922
2021/2022483 15384433 1217 2420 86412979
2022/2023138 5649627 00 00 0000
Totale 2679